Overview
Andrew Kin is a Hematologist in Detroit, Michigan. Dr. Kin is highly rated in 15 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Sickle Cell Disease, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4100 John R St, Detroit, MI 48201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Karmanos Cancer Center
Jeffrey Zonder is a Hematologist in Detroit, Michigan. Dr. Zonder is highly rated in 26 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Vertebroplasty.
Karmanos Cancer Center
Hirva Mamdani is a Hematologist in Detroit, Michigan. Dr. Mamdani has been practicing medicine for over 17 years is highly rated in 12 conditions, according to our data. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.
Karmanos Cancer Center
Voravit Ratanatharathorn is a Hematologist in Detroit, Michigan. Dr. Ratanatharathorn is highly rated in 20 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Andrew Kin
How do I make an appointment with Dr. Andrew Kin?
You can book an appointment with Dr. Andrew Kin by calling their office at 800-527-6266. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Andrew Kin a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew Kin is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Andrew Kin specialize in?
While Dr. Andrew Kin is a Hematology, they have specific expertise in Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Sickle Cell Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Andrew Kin participate in research or clinical trials?
Yes. Dr. Andrew Kin has published 18 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Andrew Kin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Andrew Kin accept my insurance?
Dr. Andrew Kin accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 800-527-6266 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Kin isDistinguished. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Sickle Cell DiseaseDr. Kin isDistinguished. Learn about Sickle Cell Disease.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Bone Marrow TransplantDr. Kin isAdvanced. Learn about Bone Marrow Transplant.
- Cardiac AmyloidosisDr. Kin isAdvanced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Kin isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- Classical Hodgkin LymphomaDr. Kin isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Aplastic AnemiaDr. Kin isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Kin isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaDr. Kin isExperienced. Learn about Burkitt Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Kin isExperienced. Learn about Childhood Acute Myeloid Leukemia.